NASDAQ:FEED Nanovibronix Q1 2026 Earnings Report $0.40 -0.09 (-17.35%) As of 09/25/2026 01:18 PM Eastern ProfileEarnings HistoryForecast Nanovibronix EPS ResultsActual EPS-$82.56Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ANanovibronix Revenue ResultsActual Revenue$0.65 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ANanovibronix Announcement DetailsQuarterQ1 2026Date5/18/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Nanovibronix Earnings HeadlinesNanovibronix, Inc. (NASDAQ:FEED) Stock Short Interest Drops 81.6%September 25 at 4:53 AM | americanbankingnews.comNanovibronix (NASDAQ:FEED) & IceCure Medical (NASDAQ:ICCM) Financial ReviewSeptember 20, 2026 | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 26 at 1:00 AM | Stansberry Research (Ad)ENvue Medical Provides Nasdaq Listing UpdateSeptember 15, 2026 | globenewswire.comENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor OrdersSeptember 9, 2026 | globenewswire.comFEED Share News TodaySeptember 8, 2026 | uk.investing.comSee More Nanovibronix Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Nanovibronix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nanovibronix and other key companies, straight to your email. Email Address About NanovibronixNanovibronix (NASDAQ:FEED) is a medical device company focused on developing and commercializing noninvasive therapeutic devices that use low-intensity surface acoustic wave technology. Its products are designed to support pain management, wound care and other clinical applications. The company’s product portfolio has included PainShield, a wearable therapeutic ultrasound device intended to provide localized pain relief, and WoundShield, a device designed to support wound-care treatment. NanoVibronix has also developed UroShield, which is intended for the management of urinary discomfort and related conditions. NanoVibronix has served healthcare providers and patients in the United States and international markets through medical distribution and sales channels. The company is associated with operations in the United States and Israel. The ticker provided, FEED, does not appear to correspond to NanoVibronix; the company has historically been identified by the Nasdaq symbol NAOV.View Nanovibronix ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/25Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin SettlementSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
